Your Article Summary
See Latest ArticlesHypercalcemia: An Evidence-Based Approach to Clinical Cases
Iranian Journal of Kidney Diseases, 07/02/09
Assadi F - Primary hyperparathyroidism and malignancy are responsible for greater than 90% of all cases of hypercalcemia. Compared with the hypercalcemia of malignancy, hyperparathyroidism tends to be associated with lower serum calcium levels (< 12 mg/dL) and a longer duration of hypercalcemia (more than 6 months). The hypercalcemic symptoms are usually fewer and subtle.
Related Articles
Recovery of paraneoplastic hypercalcemia by sunitinib treatment for renal cell carcinoma: a case report and review of the literature
Medical Oncology, 10/23/09
Relevance Score: 88%
Characterization and management of hypercalcemia following transplantation for osteopetrosis
Bone Marrow Transplantation, 10/08/09
Relevance Score: 83%
A Novel Loss-of-Function Mutation, Gln459Arg, of the Calcium-Sensing Receptor Gene Associated with Apparent Autosomal Recessive Inheritance of Familial Hypocalciuric Hypercalcemia
Journal of Clinical Endocrinology and Metabolism, 10/14/09
Relevance Score: 82%
A Case Report of 20 Lung Radiofrequency Ablation Sessions for 50 Lung Metastases from Parathyroid Carcinoma Causing Hyperparathyroidism
Cardiovascular and Interventional Radiology, 11/10/09
Relevance Score: 80%
Supportive therapy of urogenital tumors
Der Urologe, 10/13/09
Relevance Score: 80%
Today in Endocrinology...keeping you current
Receive free subspecialty "5-minute updates" via email
Muscular Strength Is Inversely Related to Prevalence and Incidence of Obesity in Adult Men
Obesity, 12/04/09
Lithium and thyroid
Best Practice & Research Clinical Endocrinology & Metabolism, 12/04/09
Selenium and thyroid
Best Practice & Research Clinical Endocrinology & Metabolism, 12/04/09